The Lethal Triad of Coronavirus Disease 2019 (COVID-19), Cardiorespiratory Disease, and Cardiac Surgery Under Cardiopulmonary Bypass
The pandemic of Coronavirus Disease 2019 (COVID-19) has created unique problems to health-care practitioners involved in cardiac sciences, particularly cardiac surgeons. Patients with underlying cardiovascular illness share the risk factors linked to increased COVID-19 mortality, making them particularly vulnerable to the lethal manifestation of COVID-19. This, together with the possible negative effects of cardiopulmonary bypass and cardiac surgery on heart and lung dynamics, could have a synergistic negative effect on the cardiorespiratory system. All cardiac surgeons must pay close attention to these three crucial criteria, which, when present in combination, might have a negative impact on surgical results.
Department of Cardiovascular and Thoracic Surgery, Paras Hospitals, Panchkula, India.
Department of Preventive Oncology, Centre for Cancer Epidemiology (CCE), Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
View Book:- https://stm.bookpi.org/NHMMR-V3/article/view/6346